2nd Longevity Therapeutics Summit 2020

Aging population is a prominent risk across the world. While major pharmas have spent decades searching for the best treatment for age-related diseases, biotechs have been secretly paving their research for longevity therapies – which could be our answers to improving our lifespan, delaying or even preventing the onset of age-related conditions.

Building on the success in 2019, the 2nd Longevity Therapeutics 2020 Summit will once again return to San Francisco. As the only industry-led and end-to-end longevity meeting, we will hear success stories in the last 12 months and explore what’s next to help you accelerate your pipeline into clinic!

Make this your 2020 must attend meeting to network with 80+ senior CSOs, CEOs, Research Scientists, Academics and Investors committed to making a change to aging diseases!

Others Details

Time: 5:00 pm to 1:00 am Speakers: Andrea Maier, Divisional Director Medicine and Community Care and Professorial Fellow General Medicine and Aged Care, University of Melbourne, Dana Larocca, VP, Discovery Research, AgeX Therapeutics and many more.